Author Archives: Jon Garvey

I think the data collection is complete enough now to be confident of the trend in COVID-19 positive tests since UK Lockdown #3 began on 5th of January. Here is today’s chart:

So today’s ONS data look even more confirmatory of a sharp improvement in national positive COVID tests beginning on January 1st. Assuming it takes 6-8 days for sudden changes in infections to show up in test patterns, it can’t be due to a lockdown starting on Jan 5th, and is very late for Tier 4 beginning on 19th December. In fact, the most obvious event in chronological terms is everyone getting together at Christmas, which is unlikely to be credited for the downturn by SAG! Most likely, as ever, it is the natural course of this particular combination of local surgesthat is the real explanation. But why does it even … Continue reading →

It’s hard to be sure as yet, but there now seems a definite downturn in the latest overall ONS “cases” data, for 4th January. The problem is that if it’s real, it begins on 1st January, 4 days before lockdown. Therefore if it continues, without a clear change in slope, lockdown is both ineffective and unnecessary. I’ll keep updating. Here’s the chart:

SARS-CoV-2 is a rather magical virus, and COVID policy displays an unprecedented degree of magical thinking. For example, unlike every other epidemic in history experts somehow knew from the start that nobody would be immune. Furthermore, no immunity would ever develop, so that we were told back in the spring that we would be required to adjust to a new normal, helpfully already prepared for us by bodies like the UN and WEF.

We all know that the overall ONS testing stats, so useful for scaring the public, are pretty useless for knowing what’s going on. Apart from the questionable nature of the (predominantly PCR) tests themselves, which may be hiding a casedemic, they are subject to a varying number of tests being done (so at least half of the present increase in cases is due to the increasing number of tests), to testing being concentrated on hot-spots rather than a consistent sample population, and increasingly to their consisting of an unspecified mix of PCR, LFT and antibody tests.